To investigate whether our in vitro data are relevant to clinical practice, immunohistochemical reactivities of FOXO1 in ovarian cancer samples, obtained at surgery before chemotherapy, with different chemotherapeutic response to paclitaxel-based chemotherapy, were examined. This evidence concerns the gene FOXO1 and ovarian cancer.